Indeed, in a Penn State study, folks taking 500 mg
Yes, GLP-1 receptor agonists can generally be used by patients without a gallbladder, though individual medical history and liver function require careful evaluation
Measurement of IGF-1 is complicated, by both the biology of IGF-1 and the recent need to differentiate the endogenous form of IGF-1, and the synthetic therapeutic forms developed to treat growth disorders
The back-to-back arguments on tirzepatide, the active ingredient in Eli Lillys Mounjaro and Zepbound, and the related semaglutide case, Novo Nordisks Ozempic and Wegovy, boiled down to two questions: Did the FDA follow the right procedure, and did it actually look at the facts fairly
Unlike some diabetes medications, they have a low risk of causing hypoglycemia (low blood sugar) because they work in a glucose-dependent manner